+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of clinical trials data shows unequivocally that Phosphodiesterase Inhibitors (PDEi) improve orgasm. The power of meta-analysis?



Comprehensive analysis of clinical trials data shows unequivocally that Phosphodiesterase Inhibitors (PDEi) improve orgasm. The power of meta-analysis?



Bju International 111(2): 190-191




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269742

Download citation: RISBibTeXText

PMID: 23356745

DOI: 10.1111/j.1464-410x.2012.11668.x


Related references

First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. Andrology 4(6): 1002-1009, 2016

Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis. Journal of Clinical Medicine Research 9(6): 488-498, 2017

Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials. Annals of the Rheumatic Diseases 72(10): 1696-1699, 2013

Effect of prolonged treatment with phosphodiesterase-5-inhibitors on endothelial dysfunction in vascular diseases and vascular risk conditions: a systematic review analysis and meta-analysis of randomized double-blind placebo-controlled trials. International Journal of Clinical Practice 2018: E13296, 2018

Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Endocrinology and Metabolism 19(4): 451-461, 2015

Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: A meta-analysis of individual patient data from randomized clinical trials. British Journal of Urology 75(2): 206-213, 1995

Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials. Acta Diabetologica 54(1): 19-36, 2016

Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials. World Journal of Urology 2018, 2018

Comparative analysis and meta-analysis of major clinical trials with oral factor Xa inhibitors versus warfarin in atrial fibrillation. Open Heart 1(1): E000080, 2014

Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials. Diabetes, Obesity and Metabolism 10(12): 1221-1238, 2008

SGLT-2 Inhibitors and DPP-4 Inhibitors as Second-Line Drugs in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials. Hormone and Metabolic Research 50(10): 768-777, 2018

Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis. Respiratory Research 17: 18, 2016

Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials. International Journal of Cardiology 143(2): 135-140, 2010

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients. International Journal of Neuropsychopharmacology 20(7): 519-528, 2017

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials. Journal of Psychiatric Research 42(2): 134-140, 2007